首页 | 本学科首页   官方微博 | 高级检索  
     


Use of recombinant factor VIIa in infants with severe coagulopathy.
Authors:Magali J Fontaine  John Lazarchick  Sarah Taylor  David Annibale
Affiliation:Department of Pathology, Transfusion Medicine Division, Medical University of South Carolina, Stanford University, Stanford, CA 94305-5626, USA. magalif@stanford.edu
Abstract:The risk of hemorrhage in infants with severe coagulopathies unresponsive to fresh frozen plasma (FFP) infusions may preclude therapeutic invasive interventional procedures. We describe the successful use of recombinant factor VIIa (rFVIIa) in two such infants, the first with cirrhosis requiring paracentesis and the second with necrotizing enterocolitis requiring laparotomy. This report reviews the current concepts on the mechanism of action of the drug rFVIIa and considers its expanded use in infants unresponsive to FFP replacement.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号